Latest News

As we step into the spring of 2024, we are delighted to present the latest edition of Patient Guard’s Newsletter, dedicated to providing you with insightful updates and invaluable resources in medical device and In Vitro Diagnostics (IVD) regulatory affairs and quality assurance consultancy.

We have been busy updating our website to change it from a generic consultancy website to an informative resource for medical device and IVD information.

March already! It’s starting to look like spring, the daffodils are out, it’s staying light for longer.  

This month we exhibited at the Medical Technology Exhibition at the Coventry Arena, here is our CEO and Founder David Small at our Stand.  It was lovely to meet many of our current customers and lots of potential new ones too. 

This month we have also been updating our website and our marketing content.  To keep UpToDate with the latest regulatory news and content from Patient Guard subscribe to our news letter.  You will receive a news letter email with the latest news at the beginning of the month, which is usually 2 to 3 weeks earlier than you will get it on our website news letter. 

In the fast-paced world of medical device manufacturing, regulatory standards are the bedrock of patient safety and product quality. Recently, the European Union has taken a significant step by extending Article 120 of the EU Regulation 2017/745 and EU Regulation 2017/746. This move has been made to address the mounting backlog of CE mark certifications and re-certifications within notified bodies, the entities responsible for ensuring that medical devices meet stringent quality and safety requirements before they reach the market. In this blog post, we’ll delve into the implications of this extension for medical device manufacturers and emphasize the critical importance of continued compliance.

As we step into the month of February, we at Patient Guard are delighted to extend our warmest greetings to you. We hope this newsletter finds you well and thriving in your respective endeavors. As always, we are committed to keeping you informed about the latest developments in the ever-evolving landscape of medical device regulatory affairs and quality assurance.

As we enter the new year, we begin planning for the upcoming year, contemplating the Regulatory and Quality Assurance requirements for Medical Devices and IVDs. In this newsletter, we provide updates from regulatory authorities and standards organizations, aiding in your planning for compliance activities.

The MHRA has unveiled a roadmap for future UK regulatory implementation, offering insights into their thought process on Medical Device and IVD Regulatory activities. The guidance outlines extended timeframes for accepting CE marked medical devices and IVDs in the UK market.

In the EU, it’s crucial to note the deadline for Manufacturers placing CE mark certified Medical Devices on the market. Those not yet transitioning to the EU MDR 2017/745 must have a contract with an EU-approved Notified Body for recertification by May 2024.

As we draw 2023 to a close, we can reflect on the year gone by and look forward to a new year.  What can we expect to see in 2024 from a Medical Device and IVD Regulatory perspective? 

The EU deadline for ensuring Manufacturers that place CE mark certified Medical Devices on the market that have not yet transitioned to the EU MDR 2017/745 have in place a contract with an EU approved Notified Body for recertification – May 2024

We are hoping to see draft regulation from the UK government on what the new UK medical device regulations will involve, which is expected to be in place by 2025.

Standards relating to medical devices are continually being updated and reviewed to ensure that they follow the most up to date thinking on safety and performance relating to the standards specific subject matter. Following medical device standards is a way of demonstrating that medical devices placed on the world market are safe effective and state of the art. All medical device regulations worldwide require manufacturers of medical devices to apply safety standards relevant to their medical devices.

The EU Commission has recently announced that the transition period for completing and implementing EUDAMED has been extended again. The previous target for full functionality was the second quarter of 2024. The new target date for this is now the second quarter of 2027.

In an era marked by unprecedented advancements in healthcare technology, the medical device industry stands as a beacon of innovation. The development of cutting-edge medical devices has transformed the way healthcare is delivered, offering more precise diagnostics, improved treatments, and enhanced patient outcomes. In this blog, we will explore the biggest medical device companies in